Creyon Bio is reinventing drug development from the ground up and making on-demand oliogonucleotide therapeutics possible.
With powerful, purpose-built data set to drive efficient creation of machine learning models, Creyon engineers oligonucleotide-based medicines (OBMs) for safe, precise gene-centric therapies with unprecedented speed and predictable efficacy and safety.
- Christopher Hart
- Swagatam Mukhopadhyay
- We are pleased to announce @DavidFajgenbaum, MD, MBA, as a Company Advisor & Board Observer. A leader in research &… https://t.co/n7H26H9Oqe
- Our Co-founder and CSO, Swagatam Mukhopadhyay, Ph.D., is presenting at #TIDESUSA May 11 on Extracting Design Rules… https://t.co/AeKSHqnVGM
- We are excited to welcome Dr. David Dimmock as our Chief Medical Officer. His passion and experience will be incred… https://t.co/CWtvjewZBf